Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Ribbon Biolabs, an Austria-based high-throughput DNA synthesis technology developer, raised €18m ($20m) in a series A round yesterday featuring IST Cube, the venture fund of Institute of Science and Technology Austria. Hadean Ventures led the round, while Lansdowne Partners, Helicase Venture, Tecnet Equity and a range of undisclosed investors also participated. IST Cube, Tecnet and…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
